Repurposing drugs: Ca(2+) ion dependency that can be exploited to treat keratitis caused by Acanthamoeba castellanii

Eitemau Tebyg

• First Reports of Effects of Insulin, Human-like Insulin Receptors and Adapter Proteins in Acanthamoeba castellanii
  gan: Baig, Abdul Mannan, et al.
  Cyhoeddwyd: (2020)
• In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype
  gan: Baig, Abdul Mannan, et al.
  Cyhoeddwyd: (2013)
• Retraction of Baig, The Charms of the CHRM Receptors: Apoptotic and Amoebicidal Effects of Dicyclomine on Acanthamoeba castellanii
  gan: Baig, Abdul Mannan
  Cyhoeddwyd: (2015)
• Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications
  gan: Baig, Abdul Mannan
  Cyhoeddwyd: (2018)
• Elucidation of cellular targets and exploitation of the receptor‐binding domain of SARS‐CoV‐2 for vaccine and monoclonal antibody synthesis
  gan: Baig, Abdul Mannan, et al.
  Cyhoeddwyd: (2020)